ask="N/A"
ask_size="N/A"
average_daily_volume="2369450"
bid="N/A"
bid_size="N/A"
book_value="-0.151"
change="-0.020"
change_from_200_day_moving_average="0.030"
change_from_50_day_moving_average="0.153"
change_from_52_week_high="-0.405"
change_From_52_week_low="0.295"
change_in_percent="-3.478%"
close="0.555"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="0.464"
ebitda="-30.10M"
eps_estimate_current_year="-0.380"
eps_estimate_next_quarter="0.000"
eps_estimate_next_year="-0.270"
ex_dividend_date="N/A"
float_shares="71947000"
high="0.592"
high_52_weeks="0.960"
last_trade_date="1/26/2017"
last_trade_price="0.555"
last_trade_size="500"
last_trade_time="4:45pm"
low="0.540"
low_52_weeks="0.260"
market_capitalization="55.40M"
moving_average_200_day="0.525"
moving_average_50_day="0.402"
name="Protalix BioTherapeutics
Inc. "
notes="N/A"
one_year_target_price="2.600"
open="0.580"
pe_ratio="1.196"
peg_ratio="-0.060"
percent_change_from_200_day_moving_average="+5.809%"
percent_change_from_50_day_moving_average="+37.914%"
percent_change_from_52_week_high="-42.187%"
percent_change_from_52_week_low="+113.462%"
previous_close="0.575"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="8.064"
revenue="7.12M"
shares_outstanding="99821000"
short_ratio="0.110"
stock_exchange="ASE"
symbol="PLX"
volume="1810320"
weeks_range_52="0.260 - 0.960"
